GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like AbbVie's PARP Inhibitor Fails to Deliver in Two Late-Stage Studies April 19, 2017 Drug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal February 15, 2018 Belgium Biotech Ablynx Files For $150 Million U.S. IPO Right After Phase III Boost October 2, 2017
